BioLife Solutions, Inc. Business Combination, Acquisition Related Costs
BioLife Solutions, Inc. (BLFS) reported Business Combination, Acquisition Related Costs of $237.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2024-05-10
- BioLife Solutions, Inc. business combination, acquisition related costs for the quarter ending 2024-03-31 was $237.00K.
- BioLife Solutions, Inc. business combination, acquisition related costs for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. business combination, acquisition related costs for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. business combination, acquisition related costs for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. business combination, acquisition related costs for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- BioLife Solutions, Inc. business combination, acquisition related costs for fiscal 2022 was $18.00K, a 98.90% decline from fiscal 2021.
- BioLife Solutions, Inc. business combination, acquisition related costs for fiscal 2021 was $1.64M, a 144.91% increase from fiscal 2020.
- BioLife Solutions, Inc. business combination, acquisition related costs for fiscal 2020 was $668.00K, a 28.94% decline from fiscal 2019.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 6 month | Business Combination, Acquisition Related Costs 9 month | Business Combination, Acquisition Related Costs 12 month |
|---|---|---|---|---|
| 2024-03-31 | $237.00K 10-Q · filed 2024-05-10 | |||
| 2023-12-31 | $0.00 10-K · filed 2024-02-29 | |||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2024-05-10 | $1.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-05-10 | $1.00K derived: sum of 3 quarters · filed 2024-05-10 | $6.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.00K derived: sum of 2 quarters · filed 2024-02-29 | $6.00K derived: sum of 3 quarters · filed 2024-02-29 | $18.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $1.00K 10-Q · filed 2022-11-09 | $6.00K derived: sum of 2 quarters · filed 2023-08-09 | $18.00K 10-Q · filed 2022-11-09 | $37.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $5.00K 10-Q · filed 2023-08-09 | $16.00K 10-Q · filed 2023-08-09 | $36.00K derived: sum of 3 quarters · filed 2024-02-29 | $381.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $11.00K 10-Q · filed 2023-05-11 | $31.00K derived: sum of 2 quarters · filed 2024-02-29 | $376.00K derived: sum of 3 quarters · filed 2024-02-29 | $648.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $365.00K derived: sum of 2 quarters · filed 2024-02-29 | $637.00K derived: sum of 3 quarters · filed 2024-02-29 | $1.64M 10-K · filed 2024-02-29 |
| 2021-09-30 | $345.00K 10-Q · filed 2022-11-09 | $617.00K derived: sum of 2 quarters · filed 2022-11-09 | $1.62M 10-Q · filed 2022-11-09 | $1.87M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-06-30 | $272.00K 10-Q · filed 2022-08-09 | $1.27M 10-Q · filed 2022-08-09 | $1.52M derived: sum of 3 quarters · filed 2023-03-31 | $1.70M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-03-31 | $998.00K 10-Q · filed 2022-05-10 | $1.25M derived: sum of 2 quarters · filed 2023-03-31 | $1.43M derived: sum of 3 quarters · filed 2023-03-31 | $1.44M derived: sum of 4 quarters · filed 2023-03-31 |
| 2020-12-31 | $251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $430.00K derived: sum of 2 quarters · filed 2023-03-31 | $443.00K derived: sum of 3 quarters · filed 2023-03-31 | $668.00K 10-K · filed 2023-03-31 |
| 2020-09-30 | $179.00K 10-Q · filed 2021-11-15 | $192.00K derived: sum of 2 quarters · filed 2021-11-15 | $417.00K 10-Q · filed 2021-11-15 | $819.00K derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-06-30 | $13.00K 10-Q · filed 2021-08-16 | $238.00K 10-Q · filed 2021-08-16 | $640.00K derived: sum of 3 quarters · filed 2022-03-31 | $931.00K derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-03-31 | $225.00K 10-Q · filed 2021-05-17 | $627.00K derived: sum of 2 quarters · filed 2022-03-31 | $918.00K derived: sum of 3 quarters · filed 2022-03-31 | $957.00K derived: sum of 4 quarters · filed 2022-03-31 |
| 2019-12-31 | $402.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $693.00K derived: sum of 2 quarters · filed 2022-03-31 | $732.00K derived: sum of 3 quarters · filed 2022-03-31 | $940.00K 10-K · filed 2022-03-31 |
| 2019-09-30 | $291.00K 10-Q · filed 2020-11-09 | $330.00K derived: sum of 2 quarters · filed 2020-11-09 | $538.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $39.00K 10-Q · filed 2020-08-10 | $247.00K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $208.00K 10-Q · filed 2020-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |